🔗 Share this article

Texas Attorney General Ken Paxton is filing a lawsuit against the producers of Tylenol, alleging the firms hid potential risks that the drug presented to children's cognitive development.

The lawsuit follows four weeks after Former President Trump publicized an unproven link between consuming Tylenol - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in offspring.

The attorney general is taking legal action against the pharmaceutical giant, which previously sold the drug, the only pain reliever suggested for pregnant women, and Kenvue, which currently produces it.

In a official comment, he claimed they "betrayed America by making money from discomfort and promoting medication regardless of the potential hazards."

The company states there is lacking scientific proof tying acetaminophen to autism.

"These companies deceived for years, knowingly endangering numerous people to increase profits," the attorney general, from the Republican party, stated.

Kenvue commented that it was "deeply concerned by the perpetuation of misinformation on the safety of acetaminophen and the likely effects that could have on the welfare of US mothers and children."

On its website, the company also mentioned it had "regularly reviewed the relevant science and there is no credible data that indicates a verified association between consuming acetaminophen and autism spectrum disorder."

Organizations acting on behalf of physicians and healthcare providers agree.

The leading OB-GYN organization has declared paracetamol - the primary component in Tylenol - is among limited choices for women during pregnancy to treat discomfort and fever, which can create significant medical dangers if left untreated.

"In multiple decades of investigation on the utilization of paracetamol in gestation, not a single reputable study has successfully concluded that the consumption of acetaminophen in any stage of gestation causes neurodevelopmental disorders in offspring," the group said.

This legal action mentions latest statements from the previous government in arguing the drug is potentially dangerous.

Last month, the former president generated worry from medical authorities when he told expectant mothers to "fight like hell" not to consume acetaminophen when unwell.

The FDA then issued a notice that medical professionals should think about restricting the use of acetaminophen, while also stating that "a causal relationship" between the drug and autism in children has remains unverified.

The Health Department head Kennedy, who manages the Food and Drug Administration, had promised in April to undertake "a massive testing and research effort" that would determine the origin of autism spectrum disorder in a limited time.

But specialists warned that finding a sole reason of autism spectrum disorder - believed by scientists to be the consequence of a intricate combination of inherited and surrounding conditions - would prove challenging.

Autism is a category of enduring cognitive variation and condition that affects how persons experience and engage with the environment, and is identified using medical professional evaluations.

In his legal document, the attorney general - who supports Trump who is running for federal office - asserts Kenvue and Johnson & Johnson "willfully ignored and sought to suppress the science" around acetaminophen and autism.

This legal action aims to force the companies "destroy any promotional materials" that claims Tylenol is safe for women during pregnancy.

The Texas lawsuit parallels the grievances of a assembly of mothers and fathers of children with autism and ADHD who took legal action against the makers of Tylenol in 2022.

The court dismissed the legal action, declaring investigations from the family's specialists was lacking definitive proof.